CatalystFDA/Bio

JAZZ PHARMACEUTICALS PLC (JAZZ) DISCUSSES FDA APPROVAL AND COMMERCIAL LAUNCH OF ZIIHERA FOR FIRST-LINE HER2-POSITIVE GEA - SLIDESHOW - SEEKINGALPHA

FDA approval and commercial launch of Zihera mark key regulatory and revenue catalysts for Jazz.

What changed

FDA approval and commercial launch of Zihera mark key regulatory and revenue catalysts for Jazz.

Why it matters

FDA approval and commercial launch of Zihera mark key regulatory and revenue catalysts for Jazz. — impact context not separately stored; see What changed.

Sources

seekingalpha